CROCCP3

Across TCGA pan-cancer cohorts, CROCCP3 Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated CROCCP3 data layer compared with 26 for mass-spec protein.

The strongest signal is observed in kidney chromophobe (KICH), where higher CROCCP3 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated CROCCP3 expression acts as an unfavorable survival marker.

KICH, UCEC, and BLCA are the cancer types where CROCCP3 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Median	All	0.102	0.848	.004	13	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
BLCA	OS	Median	All	0.161	0.616	.039	6	view →
COAD	OS	Median	III,IV	0.157	0.791	.001	6	view →
ACC	DFS	Median	All	0.195	0.748	.003	3	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

CROCCP3–KICH (DFS)

Open the KICH breakdown →